Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
format_facet:"Aufsätze"
journalStr:"Lancet (London, England)"
topic_facet:"Multicenter Study"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Multicenter+Study%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Multicenter+Study%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Multicenter+Study%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (22)
1
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002) : a single-blind, randomised, controlled, phase 2/3 trial
enthalten in:
Lancet (London, England)
| 2021
von
Ramasamy, M.
|
Minassian, A.
|
Ewer, K.
| +162
ErratumIn: Lancet. 2021 Dec 19;396(10267):1978. - PMID 33341142
Wird geladen...
2
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV) : a multicentre, randomised, controlled, phase 4 trial
enthalten in:
Lancet (London, England)
| 2021
von
Lazarus, R.
|
Baos, S.
|
Cappel-Porter, H.
| +128
Wird geladen...
3
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST) : a blinded, multicentre, randomised, controlled, phase 2 trial
enthalten in:
Lancet (London, England)
| 2021
von
Munro, A.
|
Janani, L.
|
Cornelius, V.
| +152
ErratumIn: Lancet. 2021 Dec 18;398(10318):2246. - PMID 34922669
Wird geladen...
4
Cerebral venous thrombosis after vaccination against COVID-19 in the UK : a multicentre cohort study
enthalten in:
Lancet (London, England)
| 2021
von
Perry, R.
|
Tamborska, A.
|
Singh, B.
| +74
CommentIn: Lancet. 2021 Sep 25;398(10306):1107-1109. - PMID 34370974
Wird geladen...
5
Haemodynamic-guided management of heart failure (GUIDE-HF) : a randomised controlled trial
enthalten in:
Lancet (London, England)
| 2021
von
Lindenfeld, J.
|
Zile, M.
|
Desai, A.
| +19
CommentIn: Lancet. 2021 Sep 11;398(10304):935-936. - PMID 34461039
Wird geladen...
6
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE) : a randomised, controlled, open-label, adaptive platform trial
enthalten in:
Lancet (London, England)
| 2021
von
Yu, L.
|
Bafadhel, M.
|
Dorward, J.
| +50
CommentIn: Lancet. 2021 Sep 4;398(10303):818-819. - PMID 34388397
Wird geladen...
7
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK : a prospective, multicentre cohort study
enthalten in:
Lancet (London, England)
| 2021
von
Drake, T.
|
Riad, A.
|
Fairfield, C.
| +132
CommentIn: Lancet. 2021 Jul 17;398(10296):188-190. - PMID 34274053
Wird geladen...
8
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS) : a multicentre, open-label, randomised, controlled, phase 2 trial
enthalten in:
Lancet (London, England)
| 2021
von
Borobia, A.
|
Carcas, A.
|
Pérez-Olmeda, M.
| +124
CommentIn: Lancet. 2021 Jul 10;398(10295):94-95. - PMID 34181881
Wird geladen...
9
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION) : an open-label, multicentre, randomised, controlled trial
enthalten in:
Lancet (London, England)
| 2021
von
Lopes, R.
|
de Barros E Silva, P.
|
Furtado, R.
| +46
CommentIn: Lancet. 2021 Jun 12;397(10291):2226-2228. - PMID 34119049
Wird geladen...
10
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised controlled, open-label, platform trial
enthalten in:
Lancet (London, England)
| 2021
von
RECOVERY Collaborative Group
|
Abani, O.
|
Abbas, A.
| +98
CommentIn: Lancet. 2021 May 29;397(10289):2024-2025. - PMID 34000255
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Medienart: Aufsätze
Filter aufheben
Zeitschrift: Lancet (London, England)
Filter aufheben
Thema: Multicenter Study
Medienart
Aufsätze
22
E-Artikel
22
E-Ressourcen
Zeitschriftentitel
Lancet (London, England)
Thema
22
Journal Article
Multicenter Study
19
Research Support, Non-U.S. Gov't
14
Randomized Controlled Trial
7
COVID-19 Vaccines
7
Clinical Trial, Phase II
5
B5S3K2V0G8
5
ChAdOx1 nCoV-19
4
Antibodies, Viral
4
BNT162 Vaccine
4
N38TVC63NU
3
Antibodies, Neutralizing
3
Fibrin Fibrinogen Degradation Products
3
Immunoglobulin G
3
fibrin fragment D
2
2494G1JF75
2
Clinical Trial, Phase I
2
Drug Combinations
2
Lopinavir
2
O3J8G9O825
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2019-2021
14
2021
8
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
22
Englisch
Haven't found what you're looking for?
Wird geladen...